To evaluate efficacy of Ksheerarohini Taila nasya and Gomutra Bhavit Haritaki in Vyanga (Melasma)

Single Arm Clinical Trial Of Ksheerarohini Taila Nasya And Gomutra Bhavit Haritaki in Vyanga with special reference to Melasma - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/081800

Enrollment

Registered

2025-03-06

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L814- Other melanin hyperpigmentation

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age group between 18 to 60 years 2. Patients with signs and symptoms of vyanga/melasma 3. Patients will be selected irrespective of their gender, religion, and occupation

Exclusion criteria

Exclusion criteria: 1. Pregnant women and lactating women 2. Hyper pigmentation since birth like Nevus 3. Patients who are having pitta prakruti, ati-ruksha, krusha,langhita and ksheen,after bloodletting

Design outcomes

Primary

Measure	Time frame
Improvement in Signs and Symptoms of disease like shyav varna mandal(discolouration), parush sparsh (dryness), daha(burning sensation), kandu(itching) after 21 daysTimepoint: 7th, 14th, 21st Day	—

Secondary

Measure	Time frame
Improvement in Modified MASI Score and MelasQoL after 21 daysTimepoint: 0, 21st Day	—

Countries

India

Contacts

Public ContactRupali Ramadas Patil

Hon Shri Annasaheb Dange Ayurved Medical College And Post Graduate Research Center Ashta

rupalipatil@adamc.ac.in9225633321

Outcome results